Usefulness of positron emission tomography with fluorine-18- fluorodeoxyglucose in predicting treatment response in unresectable hepatocellular carcinoma patients treated with external beam radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 3, 2012, Pages 1172-1178

  Kim, Jun Won ^a   Seong, Jinsil ^a   Yun, Mijin ^a   Lee, Ik Jae ^a   Yoon, Hong In ^a   Cho, Ho Jin ^a   Han, Kwang Hyub ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

External beam RT; FDG PET; Hepatocellular carcinoma; SUV ratio

Indexed keywords

COMPLETE RESPONSE; CONCURRENT CHEMORADIATION; CUT-OFF VALUE; DISTANT METASTASIS; EVALUATION CRITERIA; EXTERNAL BEAM; EXTERNAL BEAM RADIOTHERAPY; FDG-PET; FLUORINE-18; FLUORODEOXYGLUCOSE; HEPATOCELLULAR CARCINOMA; HIGH RATE; INTRA-ARTERIAL CHEMOTHERAPY; LIVER TISSUE; MEDIAN SURVIVAL; PARTIAL RESPONSE; RESPONSE RATE; SOLID TUMORS; STANDARDIZED UPTAKE VALUES; SUV RATIO; SUV VALUES; TRANSARTERIAL CHEMOEMBOLIZATION; TREATMENT RESPONSE;

CHEMOTHERAPY; COMPUTERIZED TOMOGRAPHY; FLUORINE; PATHOLOGY; PATIENT MONITORING; POSITRONS; RADIOTHERAPY; TUMORS;

POSITRON EMISSION TOMOGRAPHY;

FLUORODEOXYGLUCOSE F 18; FLUOROURACIL;

ABDOMINAL RADIOGRAPHY; ADULT; AGED; ARTICLE; CHEMOEMBOLIZATION; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DISTANT METASTASIS; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; LIVER; LIVER CELL CARCINOMA; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; RETROSPECTIVE STUDY; SURVIVAL; TREATMENT RESPONSE;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; CHEMORADIOTHERAPY; FEMALE; FLUORODEOXYGLUCOSE F18; FLUOROURACIL; GLUCOSE; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84856369957     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.11.076     Document Type: Article

References (35)

1. H.B. El-Serag Hepatocellular carcinoma: An epidemiologic view J Clin Gastroenterol 35 2002 S72 S78
2. L.A. Dawson, and R.K. Ten Haken Partial volume tolerance of the liver to radiation Semin Radiat Oncol 15 2005 279 283
3. F. Mornex, N. Girard, and C. Beziat Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapies - mature results of the French Phase II RTF-1 trial Int J Radiat Biol Oncol Phys 66 2006 1152 1158
4. R.V. Tse, M. Hawkins, and G. Lockwood Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma J Clin Oncol 26 2008 657 664
5. T. Chiba, K. Tokuuye, and Y. Matsuzaki Proton beam therapy for hepatocellular carcinoma: a retrospective review of 162 patients Clin Cancer Res 11 2005 3799 3805
6. L.A. Dawson, T.S. Lawrence, and W. Ensminger Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies J Clin Oncol 18 2000 2210 2218
7. J. Seong, H.C. Park, and K.H. Han Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma: A retrospective study of 158 patients Int J Radiat Biol Oncol Phys 55 2003 329 336
8. W. Guo, E. Yu, and L. Liu Comparison between chemoembolization combined with radiotherapy and chemoembolization alone for large hepatocellular carcinoma Shi Jie Chang Wei Bing Xue Za Zhi 9 2003 1697 1701
9. D. Wu, L. Liu, and L. Chen Therapeutic effects and prognostic factors in three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma Shi Jie Chang Wei Bing Xue Za Zhi 10 2004 2184 2189
10. W. Park, D.H. Lim, and S.W. Paik Local radiotherapy for patients with unresectable hepatocellular carcinoma Int J Radiat Biol Oncol Phys 61 2005 1143 1150
11. W.J. Guo, and E.X. Yu Evaluation of combined therapy with chemoembolization and irradiation for large hepatocellular carcinoma Br J Radiol 73 2000 1091 1097
12. M. Schniger-Hekele, C. Mller, and M. Kutilek Hepatocellular carcinoma in Central Europe: Prognostic features and survival Gut 48 2001 103 109
13. Z. Zeng, J. Fan, and Z. Tang Prognostic factors for patients with hepatocellular carcinoma with macroscopic portal vein or inferior vena cava tumor thrombi receiving external-beam radiation therapy Cancer Sci 99 2008 2510 2517
14. T. Nakazawa, S. Adachi, and M. Kitano Potential prognostic benefits of radiotherapy as an initial treatment for patients with unresectable advanced hepatocellular carcinoma with invasion to intrahepatic large vessels Oncol (Basel) 73 2007 90 97
15. M.J. Sweeney Comparative biochemistry of hepatomas IV. Isotopes studies of glucose and fructose metabolism in liver tumors of different growth rates Cancer Res 23 1963 995 1002
16. N.C. Choi, A.J. Fischman, and A. Niemierko Dose-response relationship between probability of pathologic tumor control and glucose metabolic rate measured with FDG PET after preoperative chemoradiotherapy in locally advanced non-small-cell lung cancer Int J Radiat Biol Oncol Phys 54 2002 1024 1035
17. C. Sperti, C. Pasquali, and F. Chierichetti 18-Fluorodeoxyglucose positron emission tomography in predicting survival of patients with pancreatic carcinoma J Gastrointest Surg 7 2003 953 959 discussion 959
18. M. Kunkel, T.E. Reichert, and P. Benz Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma Cancer 97 2003 1015 1024
19. C. Franzius, S. Bielack, and S. Flege Prognostic significance of (18)F-FDG and (99m)Tc-methylene diphosphonate uptake in primary osteosarcoma J Nucl Med 43 2002 1012 1017
20. S. Shiomi, S. Nishiguchi, and H. Ishizu Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose for predicting outcome in patients with hepatocellular carcinoma Am J Gastroenterol 96 2001 1877 1880
21. M.A. Khan, C.S. Combs, and E.M. Brunt Positron emission tomography scanning in the evaluation of hepatocellular carcinoma J Hepatol 32 2000 792 797
22. J. Trojan, O. Schroeder, and J. Raedle Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma Am J Gastroenterol 94 1999 3314 3319
23. D. Delbeke, W.H. Martin, and M.P. Sandler Evaluation of benign vs malignant hepatic lesions with positron emission tomography Arch Surg 133 1998 510 515 discussion 515
24. Y.H. Kong, C.J. Han, and S.D. Lee [Positron emission tomography with fluorine-18-fluorodeoxyglucose is useful for predicting the prognosis of patients with hepatocellular carcinoma] Korean J Hepatol 10 2004 279 287
25. J. Seong, H.C. Park, and K.H. Han Clinical results of 3-dimensional conformal radiotherapy combined with transarterial chemoembolization for hepatocellular carcinoma in the cirrhotic patients Hepatol Res 27 2003 30 35
26. J.S. Flier, M.M. Mueckler, and P. Usher Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes Science 235 1987 1492 1495
27. N.K. Monakhov, E.L. Neistadt, and M.M. Shavlovskil Physicochemical properties and isoenzyme composition of hexokinase from normal and malignant human tissues J Natl Cancer Inst 61 1978 27 34
28. W.E. Knox, S.C. Jamdar, and P.A. Davis Hexokinase, differentiation and growth rates of transplanted rat tumors Cancer Res 30 1970 2240 2244
29. J.V. Vitola, D. Delbeke, and S.G. Meranze Positron emission tomography with F-18-fluorodeoxyglucose to evaluate the results of hepatic chemoembolization Cancer 78 1996 2216 2222
30. T. Torizuka, N. Tamaki, and T. Inokuma In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET J Nuclear Med 36 1995 1811 1817
31. S.H. Cheng, J.L. Sung, and A.T. Huang A pilot study of three-dimensional conformal radiotherapy in unresectable hepatocellular carcinoma J Gastroenterol Hepatol 14 1999 1025 1033
32. S. Lee, S.Y. Nam, and K.C. Im Prediction of prognosis using standardized uptake value of 2-[(18)F] fluoro-2-deoxy-d-glucose positron emission tomography for nasopharyngeal carcinomas Radiother Oncol 87 2008 211 216
33. S.G. Swisher, J. Erasmus, and M. Maish 2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma Cancer 101 2004 1776 1785
34. S.M. Eschmann, G. Friedel, and F. Paulsen 18F-FDG PET for assessment of therapy response and preoperative re-evaluation after neoadjuvant radio-chemotherapy in stage III non-small cell lung cancer Eur J Nuclear Med Molec Imaging 34 2007 463 471
35. R.A. Medina, and G.I. Owen Glucose transporters: Expression, regulation and cancer Biol Res 35 2002 9 26